CARMEN WOOLUMS: Open Payments
NPI 1992756829 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,045 in 106 payments from 25 companies in 2025. Trend: 2023 $2,499 · 2024 $2,482 · 2025 $2,045
Food & beverage: $2,045
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $261 |
| AstraZeneca Pharmaceuticals LP | 3 | $233 |
| Novo Nordisk Inc | 10 | $179 |
| PFIZER INC. | 11 | $163 |
| Otsuka America Pharmaceutical, Inc. | 11 | $163 |
| Lilly USA, LLC | 12 | $153 |
| Exact Sciences Corporation | 5 | $103 |
| GlaxoSmithKline, LLC. | 6 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $95 |
| Lundbeck LLC | 4 | $84 |
Products named: REXULTI, FARXIGA, VRAYLAR, MOUNJARO, Cologuard Collection Kit, Ozempic, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across KY — which companies pay providers there.
